Baranovskaya IL, Sergeeva MV, Taraskin AS, Lozhkov AA, Vasin AV. Mutations designed to modify the NS gene mRNA secondary structure affect influenza A pathogenicity in vivo. MIR J 2021; 8(1), 1-9.
WHO recommendations on the composition of influenza virus vaccines for use in the 2021–2022 northern hemisphere influenza season
Komissarov, A.B., Safina, K.R., Garushyants, S.K. et al. Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia. Nat Commun 12, 649 (2021)
The list of RII's research publications has been updated with the most recent items
WHO recommendations on the composition of influenza virus vaccines for use in the 2021 southern hemisphere influenza season
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 — Eurosurveillance
RII scientists have produced the first complete genome sequence of SARS-CoV-2 from a patient in Russia. The sequence, named hCoV-19/Russia/StPetersburg-3524/2020, is available via GISAID.
WHO recommendations on the composition of influenza virus vaccines for use in the 2020–2021 northern hemisphere influenza season
Celebrating 10 Years of GISAID | A Decade of Partnership with WHO National Influenza Centre, Saint-Petersburg
Research Institute of Influenza
prof. Popov street, 15/17
Tel./fax: +7 (812) 499-15-00
Site design — Kelnik studios